IN2015DN00085A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00085A
IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
Authority
IN
India
Prior art keywords
compounds
preparation
general formula
methods
well
Prior art date
Application number
Other languages
English (en)
Inventor
Volker Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2015DN00085A publication Critical patent/IN2015DN00085A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN85DEN2015 2012-07-10 2013-07-03 IN2015DN00085A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
IN2015DN00085A true IN2015DN00085A (cg-RX-API-DMAC10.html) 2015-05-29

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85DEN2015 IN2015DN00085A (cg-RX-API-DMAC10.html) 2012-07-10 2013-07-03

Country Status (24)

Country Link
US (1) US9388177B2 (cg-RX-API-DMAC10.html)
EP (1) EP2872506A1 (cg-RX-API-DMAC10.html)
JP (1) JP6238979B2 (cg-RX-API-DMAC10.html)
KR (1) KR20150040845A (cg-RX-API-DMAC10.html)
CN (1) CN104603136B (cg-RX-API-DMAC10.html)
AP (1) AP3778A (cg-RX-API-DMAC10.html)
AU (1) AU2013289381A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015000308A2 (cg-RX-API-DMAC10.html)
CA (1) CA2878481A1 (cg-RX-API-DMAC10.html)
CL (1) CL2015000038A1 (cg-RX-API-DMAC10.html)
CO (1) CO7160002A2 (cg-RX-API-DMAC10.html)
CR (1) CR20150006A (cg-RX-API-DMAC10.html)
DO (1) DOP2015000007A (cg-RX-API-DMAC10.html)
EA (1) EA027544B1 (cg-RX-API-DMAC10.html)
HK (1) HK1206731A1 (cg-RX-API-DMAC10.html)
IL (1) IL236265A (cg-RX-API-DMAC10.html)
IN (1) IN2015DN00085A (cg-RX-API-DMAC10.html)
MX (1) MX2015000348A (cg-RX-API-DMAC10.html)
NZ (1) NZ703020A (cg-RX-API-DMAC10.html)
PE (1) PE20150354A1 (cg-RX-API-DMAC10.html)
PH (1) PH12015500061A1 (cg-RX-API-DMAC10.html)
SG (1) SG11201408419QA (cg-RX-API-DMAC10.html)
TN (1) TN2015000008A1 (cg-RX-API-DMAC10.html)
WO (1) WO2014009219A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
MA38656A1 (fr) 2013-06-11 2018-05-31 Bayer Pharma AG Combinaisons pour le traitement du cancer comprenant un inhibiteur de la kinase mps-1 et un inhibiteur de la mitose
AP2015008898A0 (en) * 2013-06-11 2015-12-31 Bayer Pharma AG Prodrug derivatives of substituted triazolopyridines
HUE064630T2 (hu) 2015-04-17 2024-04-28 Crossfire Oncology Holding B V Prognosztikai biomarkerek TTK-inhibitoros kemoterápiához
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
EP1753428A4 (en) * 2004-05-14 2010-09-15 Abbott Lab INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
MX2007004179A (es) * 2004-10-07 2007-06-07 Warner Lambert Co Derivados de triazolpiridina como agentes antibacterianos.
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
WO2007145921A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
BRPI0716239A2 (pt) 2006-08-30 2013-08-13 Cellzome Ltd derivados de triazol como inibidores de cinase
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP2178868A1 (en) 2007-07-18 2010-04-28 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
NZ584138A (en) 2007-08-23 2011-10-28 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
MX2010002312A (es) 2007-08-31 2010-03-18 Merck Serono Sa Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
WO2010092041A1 (en) 2009-02-13 2010-08-19 Fovea Pharmaceuticals Sa [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CA2760077A1 (en) 2009-04-29 2010-11-04 Marcus Koppitz Substituted imidazoquinoxalines
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
WO2010141796A2 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
CN102596932A (zh) 2009-09-04 2012-07-18 拜耳医药股份有限公司 作为酪氨酸苏氨酸激酶抑制剂的取代氨基喹喔啉
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
EA023766B1 (ru) * 2011-04-21 2016-07-29 Байер Интеллектчуал Проперти Гмбх Триазолопиридины
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
AU2013289381A1 (en) 2015-01-22
AP2014008177A0 (en) 2014-12-31
US9388177B2 (en) 2016-07-12
TN2015000008A1 (en) 2016-06-29
HK1206731A1 (en) 2016-01-15
CO7160002A2 (es) 2015-01-15
CR20150006A (es) 2015-02-16
DOP2015000007A (es) 2015-02-15
PE20150354A1 (es) 2015-03-21
PH12015500061A1 (en) 2015-03-02
CN104603136A (zh) 2015-05-06
US20150148542A1 (en) 2015-05-28
KR20150040845A (ko) 2015-04-15
SG11201408419QA (en) 2015-01-29
IL236265A (en) 2017-07-31
AP3778A (en) 2016-08-31
IL236265A0 (en) 2015-02-26
NZ703020A (en) 2017-08-25
EA027544B1 (ru) 2017-08-31
CA2878481A1 (en) 2014-01-16
BR112015000308A2 (pt) 2017-06-27
MX2015000348A (es) 2015-04-14
EA201590116A1 (ru) 2015-07-30
CL2015000038A1 (es) 2015-03-13
JP2015523372A (ja) 2015-08-13
WO2014009219A1 (en) 2014-01-16
EP2872506A1 (en) 2015-05-20
CN104603136B (zh) 2017-06-27
JP6238979B2 (ja) 2017-11-29

Similar Documents

Publication Publication Date Title
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
AU2012213775A8 (en) 7-azaindole derivatives
MD20150091A2 (ro) Compuşi antivirali
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
IL235944A0 (en) β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses
MX352881B (es) Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2.
IN2014MN02598A (cg-RX-API-DMAC10.html)
IN2014DN06104A (cg-RX-API-DMAC10.html)
EA201590887A1 (ru) Композиция
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
MY173521A (en) Trpv4 antagonists
UA114655C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2015DN00085A (cg-RX-API-DMAC10.html)
MX347541B (es) Analogos de acido sialico.
GB201107985D0 (en) Process
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor